Preparation and diagnostic use of a novel recombinant single-chain antibody against rabies virus glycoprotein.
Rabies virus (RABV) causes a fatal infectious disease, but effective protection may be achieved with the use of rabies immunoglobulin and a rabies vaccine. Virus-neutralizing antibodies (VNA), which play an important role in the prevention of rabies, are commonly evaluated by the RABV neutralizing test. For determining serum VNA levels or virus titers during the RABV vaccine manufacturing process, reliability of the assay method is highly important and mainly dependent on the diagnostic antibody. Most diagnostic antibodies are monoclonal antibodies (mAbs) made from hybridoma cell lines and are costly and time consuming to prepare. Thus, production of a cost-effective mAb for determining rabies VNA levels or RABV titers is needed. In this report, we describe the prokaryotic production of a RABV-specific single-chain variable fragment (scFv) protein with a His-tag (scFv98H) from a previously constructed plasmid in a bioreactor, including the purification and refolding process as well as the functional testing of the protein. The antigen-specific binding characteristics, affinity, and relative affinity of the purified protein were tested. The scFv98H antibody was compared with a commercial RABV nucleoprotein mAb for assaying the VNA level of anti-rabies serum samples from different sources or testing the growth kinetics of RABV strains for vaccine manufactured in China. The results indicated that scFv98H may be used as a novel diagnostic tool to assay VNA levels or virus titers and may be used as an alternative for the diagnostic antibody presently employed for these purposes.
National Engineering Laboratory for AIDS Vaccine, College of Life Science, Jilin University, Changchun, 130012, China.
Ruosen
R
Yuan
Xiaoxu
X
Chen
Yan
Y
Chen
Tiejun
T
Gu
Hualong
H
Xi
Ye
Y
Duan
Bo
B
Sun
Xianghui
X
Yu
Chunlai
C
Jiang
Xintao
X
Liu
Chunlai
C
Wu
Wei
W
Kong
Yongge
Y
Wu
D000914:Antibodies, Viral / Q000276:immunology* / Q000378:metabolism*; D006023:Glycoproteins / Q000276:immunology*; D011819:Rabies Vaccines / Q000276:immunology*; D011820:Rabies virus / Q000276:immunology* / Q000378:metabolism*; D057127:Single-Chain Antibodies / Q000096:biosynthesis*; D014764:Viral Proteins / Q000276:immunology*
D000914:Antibodies, Viral; D006023:Glycoproteins; D011819:Rabies Vaccines; D057127:Single-Chain Antibodies; D014764:Viral Proteins